Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 19/20 | 0.55 |
| ▸ | BACE2 | Q9Y5Z0 | 8/20 | 0.55 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13858956 | 0.90 | BACE1 (0.48) | BACE1BACE2CTSD | |
| SCHEMBL13859504 | 0.82 | BACE1 (0.41) | BACE1BACE2 | |
| SCHEMBL13859227 | 0.80 | BACE1 (0.36) | BACE1BACE2 | |
| SCHEMBL13858993 | 0.80 | BACE1 (0.48) | BACE1BACE2 | |
| SCHEMBL13859225 | 0.79 | BACE1 (0.55) | BACE1BACE2CTSD | |
| SCHEMBL13859466 | 0.78 | BACE1 (0.59) | BACE1BACE2 | |
| SCHEMBL1979443 | 0.78 | BACE1 (0.51) | BACE1BACE2 | |
| SCHEMBL13859217 | 0.78 | BACE1 (0.36) | BACE1BACE2 | |
| SCHEMBL1980420 | 0.78 | BACE1 (0.41) | BACE1BACE2 | |
| SCHEMBL13858862 | 0.77 | BACE1 (0.37) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2709992-A1 | 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2014-03-26 | — | — | EP | claimed |
| WO-2012156284-A1 | 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2012-11-22 | — | — | WO | claimed |
| EP-2709992-A1 | 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2014-03-26 | — | — | EP | disclosed |
| WO-2012156284-A1 | 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2012-11-22 | — | — | WO | disclosed |